CDK7 and colorectal cancer: Our study found that THZ2 may exert its inhibitory effect on colorectal cancer development by reducing the expression of β-catenin and snail in AOM/DSS mouse models, suggesting that CDK7 could potentially serve as a therapeutic target in cancer treatment by affecting β-catenin.